UNI-MB - logo
UMNIK - logo
 

Search results

Basic search    Expert search   

Currently you are NOT authorised to access e-resources UM. For full access, REGISTER.

1 2 3 4
hits: 39
1.
  • Adverse event burden in old... Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202
    Ruppert, Amy S; Booth, Allison M; Ding, Wei ... Leukemia, 10/2021, Volume: 35, Issue: 10
    Journal Article
    Peer reviewed
    Open access

    Ibrutinib has superior progression-free survival compared with bendamustine plus rituximab (BR) in older CLL patients, however, differences in treatment duration, six monthly BR cycles versus ...
Full text

PDF
2.
  • Strengthening Indigenous ey... Strengthening Indigenous eye care in Australia and New Zealand through a Leaders in Indigenous Optometry Education Network
    Bentley, Sharon A.; Anstice, Nicola S.; Armitage, James A. ... Australian and New Zealand journal of public health, April 2021, Apr 2021, 2021-Apr, 2021-04-00, 20210401, 2021-04-01, Volume: 45, Issue: 2
    Journal Article
    Peer reviewed
    Open access

    Backgrounds the aim by leaders of optometry schools in Australia and New Zealand/Aotearoa to establish a Leaders in Indigenous Optometry Education Network (LIOEN) dedicated to strengthening ...
Full text

PDF
3.
  • GenoRisk: A polygenic risk ... GenoRisk: A polygenic risk score for Alzheimer's disease
    Dickson, Samuel P.; Hendrix, Suzanne B.; Brown, Bruce L. ... Alzheimer's & dementia : translational research & clinical interventions, 2021, Volume: 7, Issue: 1
    Journal Article
    Peer reviewed
    Open access

    Introduction Recent clinical trials are considering inclusion of more than just apolipoprotein E (APOE) ε4 genotype as a way of reducing variability in analysis of outcomes. Methods Case‐control data ...
Full text

PDF
4.
  • A Prospective Economic Anal... A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia
    Cheung, Matthew C; Mittmann, Nicole; Owen, Carolyn ... Clinical lymphoma myeloma & leukemia/Clinical lymphoma, myeloma and leukemia, 11/2021, Volume: 21, Issue: 11
    Journal Article
    Peer reviewed
    Open access

    The Alliance A041202/CCTG CLC.2 trial demonstrated superior progression-free survival with ibrutinib-based therapy compared to chemoimmunotherapy with bendamustine-rituximab (BR) in previously ...
Full text
5.
  • Ibrutinib Regimens versus C... Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL
    Woyach, Jennifer A; Ruppert, Amy S; Heerema, Nyla A ... New England journal of medicine/˜The œNew England journal of medicine, 12/2018, Volume: 379, Issue: 26
    Journal Article
    Peer reviewed
    Open access

    Ibrutinib has been approved by the Food and Drug Administration for the treatment of patients with untreated chronic lymphocytic leukemia (CLL) since 2016 but has not been compared with ...
Full text

PDF
6.
Full text

PDF
7.
Full text

PDF
8.
  • Alliance A041702: A Randomi... Alliance A041702: A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (≥ 70 Years of Age) with Chronic Lymphocytic Leukemia (CLL)
    Woyach, Jennifer; Ruppert, Amy S.; Perez, Gabriela ... Blood, 11/2019, Volume: 134
    Journal Article
    Peer reviewed
    Open access

    Background The phase 3 trial A041202 solidified the Bruton's Tyrosine Kinase (BTK) inhibitor ibrutinib as a standard of care for older patients with previously untreated CLL by showing superior ...
Full text

PDF
9.
Full text

PDF
10.
  • Understanding ageing in old... Understanding ageing in older Australians: The contribution of the Dynamic Analyses to Optimise Ageing (DYNOPTA) project to the evidence base and policy
    Anstey, Kaarin J; Bielak, Allison AM; Birrell, Carole L ... Australasian journal on ageing, October 2011, Volume: 30, Issue: s2
    Journal Article
    Peer reviewed
    Open access

    Aim:  To describe the Dynamic Analyses to Optimise Ageing (DYNOPTA) project and illustrate its contributions to understanding ageing through innovative methodology, and investigations on outcomes ...
Full text

PDF
1 2 3 4
hits: 39

Load filters